Single topical ivermectin head lice treatment very effective

Single topical ivermectin head lice treatment very effective
A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England Journal of Medicine.

(HealthDay)—A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England Journal of Medicine.

David M. Pariser, M.D., from the Eastern Virginia Medical School in Norfolk, and colleagues randomly assigned 765 patients with head lice (6 months of age or older) to a single application of 0.5 percent lotion or vehicle control without nit combing.

The researchers found that a significantly greater percentage of the ivermectin group was free of lice on day two (94.9 versus 31.3 percent), day eight (85.2 versus 20.8 percent), and day 15 (73.8 versus 17.6 percent). Both groups had similar frequency and severity of adverse events.

"In conclusion, ivermectin has a well-established safety profile, on the basis of extensive oral use, and a novel mode of action," Pariser and colleagues conclude. "Topical ivermectin showed high efficacy within 24 hours, with most treated patients remaining louse-free through the final assessment two weeks after a single treatment, without the need for nit combing."

The study was funded by Topaz Pharmaceuticals (now Sanofi Pasteur), which provided the study medication; two authors disclosed to Topaz Pharmaceuticals and .

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Head lice beginning to show permethrin resistance

Jun 05, 2012

(HealthDay) -- Although live head lice obtained from school-aged children in Paris remain susceptible to the insecticide malathion, approximately 14 percent have been found to be resistant to permethrin, suggesting ...

Sequential oral, topical tacrolimus benefits dermatitis

Sep 20, 2012

(HealthDay)—Sequential therapy with oral tacrolimus and topical tacrolimus may be an effective treatment for severe atopic dermatitis (AD), according to a pilot study published in the October issue of the ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.